Propensity score-matched analysis of adjuvant chemotherapy for stage i non-small cell lung cancer

Journal of Thoracic and Cardiovascular Surgery

Volumn 148, Issue 4, 2014, Pages 1179-1185

  Tsutani, Yasuhiro ^a   Miyata, Yoshihiro ^a   Kushitani, Kei ^a   Takeshima, Yukio ^a   Yoshimura, Masahiro ^b   Okada, Morihito ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b HYOGO CANCER CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; ETOPOSIDE; GEMCITABINE; GIMERACIL PLUS OTERACIL POTASSIUM PLUS TEGAFUR; NAVELBINE; PACLITAXEL; UFT;

AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; EVALUATION STUDY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); MULTIMODALITY CANCER THERAPY; NON SMALL CELL LUNG CANCER; OVERALL SURVIVAL; POSTOPERATIVE COMPLICATION; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; SMOKING; ADJUVANT CHEMOTHERAPY; CANCER STAGING; CARCINOMA, NON-SMALL-CELL LUNG; LUNG NEOPLASMS; PATHOLOGY; PROPENSITY SCORE; RISK FACTOR; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR INVASION;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROPENSITY SCORE; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84908230787     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2014.05.084     Document Type: Article

References (13)

1. R. Arriagada, B. Bergman, A. Dunant, T. Le Chevalier, J.P. Pignon, and J. Vansteenkiste Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small cell lung cancer N Engl J Med 350 2004 351 360
2. T. Winton, R. Livingston, D. Johnson, J. Rigas, M. Johnston, and C. Butts Vinorelbine plus cisplatin vs. observation in resected non-small cell lung cancer N Engl J Med 352 2005 2589 2597
3. J. Douillard, R. Rosell, M. Delena, F. Carpagnano, R. Ramlau, and J.L. Gonzales-Larriba Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomized controlled trial Lancet Oncol 7 2006 719 727
4. G.M. Strauss, J.E. Herndon II, M.A. Maddaus, D.W. Johnstone, E.A. Johnson, and D.H. Harpole Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group study Groups J Clin Oncol 26 2008 5043 5051
5. H. Kato, Y. Ichinose, M. Ohta, E. Hata, N. Tsubota, and H. Tada A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung N Engl J Med 350 2004 1713 1721
6. C. Hamada, F. Tanaka, M. Ohta, S. Fujimura, K. Kodama, and M. Imaizumi Meta-analysis of postoperative adjuvant chemotherapy with tegafur-uracil in non-small-cell lung cancer J Clin Oncol 23 2005 4999 5006
7. C. Hamada, M. Tsuboi, M. Ohta, S. Fujimura, K. Kodama, and M. Imaizumi Effect of postoperative adjuvant chemotherapy with tegafur-uracil on survival in patients with stage IA non-small cell lung cancer: an exploratory analysis from a meta-analysis of six randomized control trials J Thorac Oncol 4 2009 1511 1516
8. P. Goldstraw, J. Crowley, K. Chansky, D.J. Giroux, P.A. Groome, and R. Rami-Porta International Association for the Study of Lung Cancer International Staging Committee; Participating Institutions. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of Malignant Tumours J Thorac Oncol 2 2007 706 714
9. M. Okada, T. Sakamoto, T. Yuki, T. Mimura, K. Miyoshi, and N. Tsubota Hybrid surgical approach of video-assisted minithoracotomy for lung cancer: significance of direct visualization on quality of surgery Chest 128 2005 2696 2701
10. M. Okada, T. Mimura, J. Ikegaki, H. Katoh, H. Itoh, and N. Tsubota A novel video-assisted anatomic segmentectomy technique: selective segmental inflation via bronchofiberoptic jet followed by cautery cutting J Thorac Cardiovasc Surg 133 2007 753 758
11. Y. Tsutani, Y. Miyata, T. Mimae, K. Kushitani, Y. Takeshima, and M. Yoshimura The prognostic role of pathologic invasive component size, excluding lepidic growth, in stage I lung adenocarcinoma J Thorac Cardiovasc Surg 146 2013 580 585
12. A. Yoshizawa, N. Motoi, G.J. Riely, C.S. Sima, W.L. Gerald, and M.G. Kris Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases Mod Pathol 24 2011 653 664
13. S.Y. Park, J.G. Lee, J. Kim, G.E. Byun, M.K. Bae, and C.Y. Lee Efficacy of platinum-based adjuvant chemotherapy in T2aN0 stage IB non-small cell lung cancer J Cardiothorac Surg 8 2013 151